financetom
Business
financetom
/
Business
/
Banks launch sale of EA buyout's $5.75 billion cross-border loan
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Banks launch sale of EA buyout's $5.75 billion cross-border loan
Mar 16, 2026 8:10 AM

WASHINGTON, March 16 (Reuters) - A JPMorgan-led group of banks on Monday began marketing to investors a $5.75 billion loan helping finance the leveraged buyout of Electronic Arts ( EA ), according to a term sheet seen by Reuters.

The seven-year term loan B consists of a $4 billion U.S. dollar portion as well as a 1.531 billion euro ($1.75 billion-equivalent) portion, according to the term sheet, which will help finance game publisher EA's $55 billion take-private deal by a consortium of investors including Saudi Arabia's Public Investment Fund, Silver Lake and Affinity Partners.

There is also a $3.25 billion term loan A and $9 billion in other dollar and euro-denominated secured and unsecured debt, according to the term sheet. 

The take-private deal is expected to close in June, according to the firms' September announcement.

The banks are marketing the $4 billion portion and the 1.531 billion euro portion of the term loan B at a discounted 98.5 cents on the dollar and a floating interest rate of 350 basis points (bps) to 375 bps over the Secured Overnight Financing Rate (SOFR) and the Euro Interbank Offered Rate (Euribor), respectively, according to the term sheet.

The loan sale's deadline is currently set for market close on March 23, according to the term sheet.

EA did not immediately respond to a request for comment. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson Says Combined Talvey-Tecvayli Treatment Showed 'High' Response Rates in Blood Cancer Study
Johnson & Johnson Says Combined Talvey-Tecvayli Treatment Showed 'High' Response Rates in Blood Cancer Study
Sep 27, 2024
09:03 AM EDT, 09/27/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday updated results from the investigational phase 1b study assessing the combination of Talvey and Tecvayli showed high response rates in triple-class refractory patients with relapsed or refractory multiple myeloma, including those with extramedullary disease. The overall response rate was 79.5% at data cutoff for patients...
Canada's Job Market Balance Is Shifting Rapidly, Says BMO
Canada's Job Market Balance Is Shifting Rapidly, Says BMO
Sep 27, 2024
08:43 AM EDT, 09/27/2024 (MT Newswires) -- Little more than two years ago, there were one million vacant jobs in Canada, and there were little more than one million unemployed Canadians, noted Bank of Montreal (BMO). Vacancies have since been sliced in half and the number of unemployed has vaulted to nearly 1.5 million. This has sent the unemployed-to-vacant jobs...
Dropbox Insider Sold Shares Worth $3,655,622, According to a Recent SEC Filing
Dropbox Insider Sold Shares Worth $3,655,622, According to a Recent SEC Filing
Sep 27, 2024
09:25 AM EDT, 09/27/2024 (MT Newswires) -- Andrew Houston, 10% Owner, Director, Chief Executive Officer, around September 24, 2024, sold 146,094 shares in Dropbox ( DBX ) for $3,655,622. Following the Form 4 filing with the SEC, Houston has control over a total of 9,427,838 shares of the company, with 8,266,666 shares held directly and 1,161,172 shares controlled indirectly. SEC...
Johnson & Johnson Says Results From Blood Cancer Drug Study Support Further Evaluation
Johnson & Johnson Says Results From Blood Cancer Drug Study Support Further Evaluation
Sep 27, 2024
08:41 AM EDT, 09/27/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that an investigational phase 1 study evaluating the combination of Talvey with Darzalex Faspro and pomalidomide in patients with relapsed or refractory multiple myeloma showed an overall response rate of 82%. The company said the data supports continued investigation of the drug combination. The study...
Copyright 2023-2026 - www.financetom.com All Rights Reserved